Young Kids Could Spread COVID-19 as Much as Older Children and Adults, Study Suggests

A study from Ann & Robert H. Lurie Children’s Hospital of Chicago discovered that children younger than 5 years with mild to moderate COVID-19 have much higher levels of genetic material for the virus in the nose compared to older children and adults.

Findings, published in JAMA Pediatrics, point to the possibility that the youngest children transmit the virus as much as other age groups. The ability of younger children to spread COVID-19 may have been under-recognized given the rapid and sustained closure of schools and daycare during the pandemic.

“We found that children under 5 with COVID-19 have a higher viral load than older children and adults, which may suggest greater transmission, as we see with respiratory syncytial virus, also known as RSV,” says lead author Taylor Heald-Sargent, MD, PhD, pediatric infectious diseases specialist at Lurie Children’s and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine. “This has important public health implications, especially during discussions on the safety of reopening schools and daycare.”

Dr. Heald-Sargent and colleagues analyzed 145 cases of mild to moderate COVID-19 illness within the first week of symptom onset. They compared the viral load in three age groups — children younger than 5 years, children 5-17 years and adults 18-65 years.

“Our study was not designed to prove that younger children spread COVID-19 as much as adults, but it is a possibility,” says Dr. Heald-Sargent. “We need to take that into account in efforts to reduce transmission as we continue to learn more about this virus.”

Advertisement
 

Story Source:

Materials provided by Ann & Robert H. Lurie Children’s Hospital of ChicagoNote: Content may be edited for style and length.


Journal Reference:

Advertisement
  1. Taylor Heald-Sargent, William J. Muller, Xiaotian Zheng, Jason Rippe, Ami B. Patel, Larry K. Kociolek. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)JAMA Pediatrics, July 30, 2020; DOI: 10.1001/jamapediatrics.2020.3651
Nov 23
New Simulation Finds Max Cost for Cost-Effective Health Treatments

As health care costs balloon in the U.S., experts say it may be important to analyze…

Nov 19
Life After COVID Hospitalization: Study Shows Major Lasting Effects on Health, Work and More

Surviving a case of COVID-19 that’s bad enough to land you in the hospital is…

Comments

mood_bad
  • No comments yet.
  • Add a comment